Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma
Conditions: Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type; T-lymphoblastic Lymphoma Interventions: Drug: Linperlisib; Drug: Camrelizumab; Drug: Pegaspargase; Drug: Dexamethasone Sponsors: Beijing Tongren Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density
Conditions: Acute Lymphoblastic Leukemia Sponsors: University of Aarhus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF : Double Blinded, Randomized Control Trial
Conditions: Spinal Stenosis Lumbar; Disc Degeneration; Disc Disease; Fusion of Spine; Surgery Interventions: Drug: Dexamethasone; Drug: Normal saline Sponsors: Potsawat Surabotsopon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries
DiscussionThis trial will evaluate the benefits and possible harms of ACS when used in women likely to have a late preterm birth. It will also evaluate a lower-dose ACS regimen based on literature from pharmacokinetic studies. The results of this trial will provide robust critical evidence on the safe and appropriate use of ACS in the late preterm period internationally.Trial registrationISRCTN11434567. Registered on 7 June 2021. (Source: Trials)
Source: Trials - April 12, 2024 Category: Research Source Type: clinical trials
A Phase III Study Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL
Conditions: ETP-ALL Interventions: Drug: Homoharringtonine; Drug: venetoclax; Drug: Cytarabine; Drug: G-CSF; Drug: Vindesine; Drug: Daunorubicin; Drug: cyclophosphamide; Drug: Dexamethasone; Drug: L-ASP Sponsors: First Affiliated Hospital of Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Conditions: Plasma Cell Myeloma Refractory Interventions: Drug: Isatuximab SC-OBDS; Drug: Montelukast; Drug: Dexamethasone; Drug: Acetaminophen; Drug: Diphenhydramine; Drug: Methylprednisolone; Drug: Carfilzomib Sponsors: Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Infraclavicular Brachial Plexus Block With Bupivacaine Alone or With Both Dexmedetomidine and Dexamethasone
Conditions: Upper Extremity Injury Interventions: Drug: Bupivacaine injection; Drug: Bupivacaine+ Dexamethasone+ Dexmedetomidine Sponsors: Suez Canal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma Interventions: Drug: Teclistamab; Drug: Talquetamab; Drug: Lenalidomide; Drug: Bortezomib; Drug: Daratumumab; Drug: Dexamethasone Sponsors: Nantes University Hospital; Janssen Pharmaceutica Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Conditions: Relapsed and/or Refractory Multiple Myeloma Interventions: Drug: ON 123300; Drug: Dexamethasone Sponsors: Adriana Rossi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
A Clinical Pharmacological Study of Dose Halving of Dexamethasone in Pregnant Women With Preterm Labour With Preterm Birth at Greater Than or Equal to 34 Gestational Weeks (34GW+)
Conditions: Respiratory Distress Syndrome of Newborn Interventions: Drug: Dexamethasone Sponsors: Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma; Refractory Multiple Myeloma; Relapsed Multiple Myeloma Interventions: Biological: Talquetamab; Drug: Iberdomide; Drug: Dexamethasone; Procedure: Bone Marrow Biopsy Sponsors: Thomas Martin, MD; Bristol-Myers Squibb; Janssen Research& Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation
Conditions: Newly Diagnosed Multiple Myeloma; Multiple Myeloma; Autologous Stem Cell Transplantation Interventions: Biological: Daratumumab; Drug: Lenalidomide; Drug: Bortezomib; Drug: Dexamethasone Sponsors: UNC Lineberger Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Bortezomib, Pomalidomide, Dexamethasone For Systemic AL Amyloidosis
Conditions: Systemic Amyloidosis Interventions: Drug: Bortezomib; Drug: Pomalidomide; Drug: Dexamethasone Sponsors: Jin Lu, MD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Comparing Single Dose and Multiple Dose of Dexamethasone Post TKA
Conditions: Osteo Arthritis Knee; Pain, Postoperative Interventions: Drug: Dexamethasone before surgery; Drug: Dexamethasone before and 12 hours after surgery; Drug: Dexamethasone before and 24 hours after surgery Sponsors: Thammasat University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Ma-Spore ALL 2020 Study
Conditions: B Lymphoblastic Leukemia Interventions: Drug: Prednisolone; Drug: Dexamethasone; Drug: Vincristine; Drug: Methotrexate; Drug: L-Asparaginase; Drug: Pegylated asparaginase; Drug: Erwinase; Drug: Dasatinib; Drug: Imatinib; Drug: Cyclophosphamide; Drug: Cytarabine; Drug: Mercaptopurine; Drug: Thioguanine; Drug: Rituximab; Drug: Doxorubicin; Drug: Fludarabine Sponsors: National University Hospital, Singapore Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
